Prevalence of anti-retinal autoantibodies in different stages of Age-related macular degeneration.
Prevalence of anti-retinal autoantibodies in different stages of Age-related macular degeneration.
复制标题
DOI：
10.1186/1471-2415-14-154
复制
发表时间：
2014-12-08
影响因子：
2
通讯作者：
Klein ML
中科院分区：
文献类型：
--
作者：
Adamus G;Chew EY;Ferris FL;Klein ML
Age-related macular degeneration (AMD) is the leading cause of central vision loss in older adults. Anti-retinal autoantibodies (AAbs) have been found in individuals with AMD. The goal of the study was to determine the AAb specificity in different stages of AMD, and determine whether there is a prevalent AAb signature. Sera of 134 participants in the Age-related Eye Disease Study were analyzed for anti-retinal AAbs by western blotting. The subjects were classified by diagnostic subgroups based upon their clinical classification: No AMD, Intermediate AMD, and Late AMD - geographic atrophy (GA) and Late AMD - neovascular (NV). The presence of anti-retinal AAb was detected in 58% patients with Intermediate and Late AMD, and 54% of those with no AMD. AAbs bound to fifteen different retinal antigens. Most individuals had 1 specific AAbs (67%), with the remainder having 2 to 4 different AAbs. Over 40% of patients with Intermediate AMD, and 46% of those with GA had anti-enolase AAbs, compared with 29% of individuals with NV and 29% with no AMD. Different AAbs signatures related to NV as compared to GA and/or Intermediate AMD were distinguished. Anti-40-kDa (10%) and 42-kDa (16%) autoantibodies were associated with Intermediate AMD, while anti-30-kDa AAbs (23%) were primarily present in GA. Anti-32-kDa (12%), 35-kDa (21%), and 60-kDa (8%) AAbs were more frequent in NV AMD. A unique AAb pattern for each of the disease subgroups was present when AMD progressed from the intermediate to the late forms of severity. Differences in the frequency of specific AAbs between AMD subgroups suggested that they may participate in pathogenicity of AMD. Further studies are necessary to confirm these observations in the larger cohort and individual AMD patients over time.
登录
查看更多内容
自身抗体靶标及其在副肿瘤性视网膜病的致病性中的癌症关系。
影响因子：
13.6
作者：
Adamus, Grazyna
通讯作者：
Adamus, Grazyna
影响因子：
4.9
作者：
Cutolo M;Straub RH
通讯作者：
Straub RH
影响因子：
3.4
作者：
Chen, Mei;Forrester, John V.;Xu, Heping
通讯作者：
Xu, Heping
影响因子：
5
作者：
Adamus, Grazyna;Chan, Chi-Chao
通讯作者：
Chan, Chi-Chao
影响因子：
--
作者：
Deeg, Cornelia A.;Raith, Albert J.;Stangassinger, Manfred
通讯作者：
Stangassinger, Manfred